These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 8353477

  • 1. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY, Gninafon M, Josse R, Kinde-Gazard D, Tawo L, Foundohou J.
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [Abstract] [Full Text] [Related]

  • 2. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS, Gupta S, Lal S.
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [Abstract] [Full Text] [Related]

  • 3. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI, El'shanskaia MP.
    Probl Tuberk; 1973 Jun; 51(12):60-4. PubMed ID: 4205666
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 5. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 6. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT, Joshi RM, Rizghalla T.
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [Abstract] [Full Text] [Related]

  • 7. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F, Centrella G, Stefanelli R.
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
    Meissner G.
    Acta Tuberc Pneumol Belg; 1969 May; 60(3):554-6. PubMed ID: 4906103
    [No Abstract] [Full Text] [Related]

  • 13. Five years of clinical experience with rifampicin.
    Gyselen A, Cosemans J, Lacquet LM, Vandenbergh E, Verbist L.
    Acta Tuberc Pneumol Belg; 1971 May; 62(4):289-307. PubMed ID: 4948635
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E.
    Dtsch Med Wochenschr; 1970 Jan 16; 95(3):139-41. PubMed ID: 5411222
    [No Abstract] [Full Text] [Related]

  • 16. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 16; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 17. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M, Ouedraogo SM, Diagbouga S, Coulibaly G, Achi V, Domoua K, N'Dathz M, Yapi A.
    Rev Mal Respir; 2000 Apr 16; 17(2):477-80. PubMed ID: 10859766
    [Abstract] [Full Text] [Related]

  • 18. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S, Sasaki M, Kobayashi T, Matsuda T.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep 16; 19(2):84-8. PubMed ID: 4649627
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A.
    Acta Tuberc Pneumol Belg; 1972 Sep 16; 63(4):405-8. PubMed ID: 4206438
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.